Aurore Life Sciences Revenue and Competitors

Established in 2017, We are a pure-play Active Pharmaceutical Ingredient (API) company keen on delivering superior products in a regulatory compliant environment. We are backed up with manufacturing facilities in India with a combined manufacturing capacity of 600 KL and our flagship facility in Hyderabad in approved with USFDA, EDQM, WHO Geneva, COFEPRIS, KFDA amongst other regulatory agencies. Our facilities, coupled with a dedicated R&D setup, complement our strategy to be a fully integrated API company with complete control of key starting materials, advanced intermediates and high-quality final product. With a strong team of R&D experts that complements our strategy, Aurore is rapidly emerging as the most preferred API and key API intermediates supply partner for leading global pharmaceutical companies. With a robust portfolio of niche and differentiated molecule spread across major therapeutic divisions, we are rapidly establishing ourselves as a reliable partner to serve unmet demands of the market.